# GCC Structural Heart Devices Market

> GCC Structural Heart Devices Market Research Report: By Type (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy) andBy Procedure (Replacement Procedures, Repair Procedures) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.72%
- **2024:** $ 19.25 Million
- **2025:** $ 20.54 Million
- **2035:** $ 39.36 Million
- **Key Players:** Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US)

**Report ID:** MRFR/MED/55139-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/gcc-structural-heart-devices-market-56905

---

## Market Summary

## **GCC Structural Heart Devices Market Overview****:**

As per MRFR analysis, the GCC Structural Heart Devices Market Size was estimated at 17.75 (USD Million) in 2024.The GCC Structural Heart Devices Market Industry is expected to grow from 19.25(USD Million) in 2025 to 48 (USD Million) by 2035. The GCC Structural Heart Devices Market CAGR (growth rate) is expected to be around 8.661% during the forecast period (2025 - 2035).

### **Key GCC Structural Heart Devices Market Trends Highlighted**

The GCC Structural Heart Devices Market is witnessing notable trends driven by advancements in medical technology and increasing healthcare investments in the region. One significant market driver is the growing prevalence of cardiovascular diseases in GCC nations, which has prompted governments to enhance focus on cardiology and structural heart interventions. 

This rising concern around heart health is leading to a surge in demand for innovative devices such as transcatheter heart valves and left atrial appendage closures. Moreover, the region is experiencing an increase in disposable income and health awareness among the population, further driving the demand for advanced healthcare solutions.Opportunities to be explored include partnerships between local healthcare systems and international medical device manufacturers, facilitating knowledge transfer and innovation within the market. Public-private collaboration is also emerging as a key strategy to enhance the quality of care and to further develop the structural heart devices sector.

In recent times, there has been a noticeable trend towards the adoption of less invasive surgical techniques in the GCC, which aligns with global practices aimed at improving patient recovery times and outcomes. 

This trend reflects an increased availability of training programs for medical professionals in advanced surgical techniques.Countries like Saudi Arabia and the UAE are increasingly investing in healthcare infrastructure and specialized training, paving the way for more advanced treatment options for patients with structural heart conditions. As regulatory frameworks evolve to support these innovations, the GCC Structural Heart Devices Market is positioned for continued growth through technological advancements and enhanced patient care strategies.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **GCC Structural Heart Devices Market Drivers**

### **Rising Prevalence of Cardiovascular Diseases in the GCC Region**

The increasing prevalence of cardiovascular diseases (CVD) in the Gulf Cooperation Council (GCC) countries is a significant driver for the GCC [Structural Heart Devices Market](../../../reports/structural-heart-devices-market-6385) Industry. According to data from the World Health Organization, CVDs are projected to account for approximately 40% of all deaths in the Gulf region by 2030. This alarming statistic emphasizes the urgent need for effective treatments, leading to higher demand for structural heart devices.

Factors contributing to this growth include changing lifestyles, increased urbanization, and rising obesity rates across GCC nations. Governments in the region, especially in Saudi Arabia and the United Arab Emirates, have recognized this health crisis and are allocating substantial funding towards public health initiatives aimed at combating the epidemic of heart disease. For instance, the Saudi Health Ministry has launched campaigns focused on preventive healthcare and advanced medical technologies, thereby creating a more favorable environment for the growth of structural heart devices.

### **Technological Advancements in Structural Heart Devices**

Rapid advancements in technology are driving the GCC Structural Heart Devices Market significantly. Innovations such as minimally invasive procedures and the development of new transcatheter devices are changing the landscape of cardiovascular treatment. For example, the adoption of 3D printing technology for customized heart devices is enhancing the efficacy and safety of cardiovascular interventions.

Established companies such as Abbott and Boston Scientific are continuously investing in Research and Development (R&D) to introduce advanced products tailored for the GCC market.Fostering this culture of innovation addresses the specific anatomical differences within the GCC population, in turn improving patient outcomes and advancing the region's market growth.

### **Government Initiatives and Healthcare Investments**

Government initiatives aimed at improving healthcare infrastructure in the GCC region are driving the growth of the GCC Structural Heart Devices Market. The Health Ministry in the United Arab Emirates has implemented a comprehensive healthcare strategy that calls for the enhancement of cardiac care services as part of its agenda to elevate healthcare standards. In particular, they are investing heavily in public-private partnerships to improve the delivery of health services and medical devices.This is evident in policies encouraging the establishment of advanced cardiac care centers equipped with the latest structural heart technologies.

A report from the Saudi Arabian Ministry of Health reveals an increase in budget allocations for cardiovascular health care, signaling a robust commitment to investing in heart disease prevention and treatment solutions, ultimately leading to growth in thestructural heart devices market.

## **GCC Structural Heart Devices Market Segment Insights****:**

### **Structural Heart Devices Market Type Insights**

The GCC Structural Heart Devices Market exhibits a significant concentration on the Type segment, consisting of various critical categories like Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems. Heart Valve Devices play a pivotal role in treating heart valve diseases, with increasing prevalence among the aging population in the GCC region. These devices are crucial as they address severe health issues and offer patients improved quality of life. 

Annuloplasty Rings are also crucial within this segment, as they provide a minimally invasive option for correcting valve dysfunction, thus contributing to better surgical outcomes.Occluders have gained traction due to their effectiveness in closing holes in the heart, particularly septal defects, and they are often preferred for their less invasive nature. Delivery Systems, instrumental in ensuring the precision of device placement during procedures, further enhance the overall efficiency of treatments, making them indispensable in cardiac surgeries.

The emphasis on innovation and technological advancements is paramount, as manufacturers and healthcare providers in the GCC consistently seek to enhance the performance of these devices.

This dynamic landscape is driven by the rising prevalence of cardiovascular diseases, patient demand for minimally invasive procedures, and ongoing research and development initiatives aimed at improving device efficacy and safety. As a result, these segments collectively contribute to the profound evolution of the GCC Structural Heart Devices Market, positioning the region at the forefront of the global cardiovascular device industry. Increased healthcare expenditure and government initiatives aimed at enhancing healthcare infrastructure further bolster market growth, allowing for greater accessibility and adoption of cutting-edge heart devices across the GCC nations.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Structural Heart Devices Market Indication Insights**

The GCC Structural Heart Devices Market is rapidly evolving, showing significant potential particularly within the Indication segment. Notably, Valvular Heart Disease and Cardiomyopathy exhibit remarkable relevance in this context. Valvular Heart Disease represents a critical area, as it affects a substantial portion of the population, prompting increased demand for effective treatment options. This condition often necessitates advanced interventions, contributing to its prominence in the device market. 

On the other hand, Cardiomyopathy presents unique challenges, as it can lead to debilitating heart function and requires innovative device solutions that enhance patient outcomes.The GCC region, with its growing healthcare investments and a rising prevalence of cardiovascular diseases, is positioned for substantial growth in these areas. Additionally, the increasing awareness and diagnostic advancements are likely to fortify the market dynamics. The ongoing collaboration between research institutions and healthcare providers further underscores the importance of addressing these issues, reinforcing the GCC’s commitment to improving cardiac healthcare.

### **Structural Heart Devices Market Procedure Insights**

The Procedure segment of the GCC Structural Heart Devices Market encompasses critical interventions aimed at treating various cardiac conditions, specifically focusing on Replacement Procedures and Repair Procedures. Replacement Procedures are essential for patients with damaged or dysfunctional heart valves, significantly improving their quality of life and survival rates. This method is largely preferred due to advancements in technology, which enhance safety and efficacy. 

Repair Procedures, on the other hand, are vital for less severe heart ailments, allowing for minimally invasive approaches that reduce recovery times and complications.The demand for these procedures is driven by the increasing prevalence of cardiovascular diseases in the GCC region, coupled with a growing geriatric population. Furthermore, supportive healthcare policies and investments in medical infrastructure in countries such as Saudi Arabia and UAE are enhancing access to these vital procedures. 

The rising awareness among healthcare professionals and patients about the existence and benefits of these advanced treatment options contributes to the strong adoption of both Replacement and Repair Procedures in the market.The ongoing research and innovation in this space further support the expansion of the GCC Structural Heart Devices Market, leading to improved patient outcomes.

## **GCC Structural Heart Devices Market Key Players and Competitive Insights****:**

The GCC Structural Heart Devices Market is experiencing significant growth, driven by an increase in the prevalence of cardiovascular diseases, rapid advancements in medical technology, and an increased focus on personalized healthcare solutions. The competitive landscape in this region is characterized by a mix of established players and emerging companies, all vying for market share through innovation and strategic collaborations. Regulatory approvals and the introduction of innovative products are crucial factors that shape competition in this market. 

Companies are continually investing in research and development to create minimally invasive devices that enhance patient outcomes and reduce hospital stays. As the market evolves, understanding the competitive strategies, product offerings, and market positioning of key players becomes essential for stakeholders looking to navigate this dynamic landscape.Medtronic stands out in the GCC Structural Heart Devices Market with its strong reputation for reliability and innovation. 

The company has a robust portfolio that includes advanced technologies for mitral and aortic valve interventions, showcasing its commitment to addressing a wide range of structural heart conditions. Medtronic benefits from its expansive distribution network, which ensures efficient delivery of its products throughout the GCC region. Additionally, the company's focus on clinical research and partnerships with healthcare organizations enhances its credibility and fosters relationships with healthcare professionals. 

With a strong emphasis on training and education for healthcare providers, Medtronic is well-positioned to maintain its competitive edge and continue to expand its market presence in the region.LifeTech is also a significant player in the GCC Structural Heart Devices Market, specializing in innovative cardiac intervention products such as occluders and stents. The company has developed a variety of key products aimed at treating structural heart issues, which are gaining traction among healthcare providers in the region.

LifeTech's strengths lie in its commitment to research and development, allowing the company to continuously introduce cutting-edge solutions tailored to the specific needs of the GCC market. 

Furthermore, through various strategic partnerships and collaborations, LifeTech has enhanced its market presence and product accessibility. The company's focus on tailored solutions showcases its adaptability to regional healthcare challenges, making it a strong contender in the competitive landscape of the GCC Structural Heart Devices Market. Its ability to engage in strategic mergers and acquisitions further bolsters its capabilities and establishes its footprint in this vital sector.

### **Key Companies in the GCC Structural Heart Devices Market Include:**

- Medtronic
- LifeTech
- Terumo
- AtriCure
- Abbott Laboratories
- Getinge
- Boston Scientific
- Cardinal Health
- Cook Medical
- Sorin Group
- Alcon
- LivaNova
- B. Braun
- Edwards Lifesciences
- Johnson & Johnson

## **GCC Structural Heart Devices Market Industry Developments**

_The GCC Structural Heart Devices Market has recently seen significant developments, particularly from key players such as Medtronic, Abbott Laboratories, and Boston Scientific. In October 2023, Medtronic announced a partnership with several healthcare institutions across the GCC for the introduction of innovative heart valve therapies, responding to the rising prevalence of cardiovascular diseases in the region. Additionally, Abbott Laboratories revealed advancements in their medical devices aimed at improving patient outcomes, showcasing their continued commitment to Research and Development in the region. _

In terms of mergers and acquisitions, there have been whispers regarding possible acquisition discussions involving Terumo and AtriCure as of September 2023. The market is poised for growth due to increased investments in healthcare infrastructure across the GCC, driven by government initiatives aimed at enhancing health services. The overall market valuation of structural heart devices is projected to rise, reflecting the increasing demand for advanced medical solutions.

Recently, the UAE Ministry of Health and Prevention also indicated an ongoing trend toward the localization of medical manufacturing, which is likely to impact supply chains and the availability of these devices in the region moving forward.

## **GCC Structural Heart Devices Market Segmentation Insights**

### **Structural Heart Devices Market Type****Outlook**

- Heart Valve Devices
- Annuloplasty Rings
- Occluders
- Delivery Systems

### **Structural Heart Devices Market Indication****Outlook**

- Valvular Heart Disease
- Cardiomyopathy

### **Structural Heart Devices Market Procedure****Outlook**

- Replacement Procedures
- Repair Procedures

## Market Drivers

### Aging Population

The demographic shift towards an aging population in the GCC region is a notable driver for the structural heart devices market. As life expectancy increases, the incidence of age-related cardiovascular conditions is also rising. This demographic trend necessitates the development and deployment of advanced medical devices tailored to the needs of older patients. The structural heart-devices market is poised to benefit from this shift, as healthcare providers seek effective solutions to manage the complexities associated with aging. It is estimated that by 2030, the proportion of individuals aged 60 and above in the GCC will increase significantly, further amplifying the demand for specialized heart devices. This evolving demographic landscape suggests a sustained growth potential for the market.

### Investment in Healthcare Infrastructure

The GCC countries are witnessing substantial investments in healthcare infrastructure, which is a crucial driver for the structural heart devices market. Governments are prioritizing healthcare as part of their national development plans, leading to the establishment of advanced medical facilities and specialized centers. This investment is expected to enhance the accessibility and quality of healthcare services, thereby increasing the adoption of structural heart devices. For instance, the healthcare expenditure in the GCC is projected to reach approximately $100 billion by 2025, indicating a strong commitment to improving health outcomes. As more hospitals are equipped with cutting-edge technology, the structural heart-devices market is likely to experience significant growth, driven by the demand for innovative treatment options.

### Increased Focus on Preventive Healthcare

There is a growing emphasis on preventive healthcare in the GCC, which serves as a significant driver for the structural heart devices market. As awareness of cardiovascular health increases, more individuals are seeking early interventions and screenings. This shift towards preventive measures is likely to result in higher demand for structural heart devices, as healthcare systems aim to address issues before they escalate. The structural heart-devices market may benefit from initiatives promoting regular health check-ups and lifestyle modifications, which can lead to earlier diagnoses and treatments. Consequently, the market is expected to expand as healthcare providers adapt to this proactive approach, integrating advanced devices into their preventive care strategies.

### Technological Innovations in Device Design

Technological innovations in the design and functionality of structural heart devices are driving the market forward. The introduction of minimally invasive procedures and advanced materials has revolutionized treatment options for patients with structural heart issues. These innovations not only improve patient outcomes but also reduce recovery times, making them more appealing to both healthcare providers and patients. The structural heart devices market is likely to see a surge in demand as new technologies emerge, offering enhanced performance and safety. Furthermore, ongoing research and development efforts in the GCC are expected to yield novel devices that cater to specific patient needs, thereby expanding the market's potential.

### Rising Incidence of Cardiovascular Diseases

The increasing prevalence of cardiovascular diseases in the GCC region is a primary driver for the structural heart devices market. As lifestyle-related health issues become more common, the demand for innovative treatment options rises. Reports indicate that cardiovascular diseases account for a significant portion of mortality rates in the region, prompting healthcare providers to seek advanced solutions. The structural heart-devices market is expected to grow as hospitals and clinics invest in state-of-the-art technologies to address these health challenges. Furthermore, the GCC governments are likely to allocate more resources towards healthcare infrastructure, enhancing the availability of these devices. This trend suggests a robust growth trajectory for the market, as the need for effective interventions becomes increasingly urgent.

## Future Outlook

The [Structural Heart Devices Market](https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385) is projected to grow at a 6.72% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.

**New opportunities:**

- Development of minimally invasive surgical techniques for device implantation.
- Expansion of telehealth services for remote patient monitoring and follow-up.
- Partnerships with local healthcare providers to enhance distribution networks.

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships.

## Segment Insights

### By Type: Transcatheter Aortic Valve Replacement (Largest) vs. Mitral Valve Repair Devices (Fastest-Growing)

The GCC structural heart-devices market displays a segmented structure with Transcatheter Aortic Valve Replacement (TAVR) holding the largest market share due to its established position and increasing adoption rates among healthcare providers. In contrast, Mitral Valve Repair Devices are rapidly gaining traction, driven by advancements in technology and rising awareness of minimally invasive surgical options. 

The growth trends within this segment are largely influenced by factors such as the aging population and an increase in cardiovascular diseases. As more healthcare facilities adopt innovative treatment solutions, the demand for Left Atrial Appendage Closure Devices and Transcatheter Pulmonary Valve options is also expected to rise, reflecting a dynamic and competitive market environment focused on enhancing patient outcomes.

Transcatheter Aortic Valve Replacement (Dominant) vs. Mitral Valve Repair Devices (Emerging)

Transcatheter Aortic Valve Replacement (TAVR) remains the dominant force within the GCC structural heart-devices market, characterized by its established efficacy in treating severe aortic stenosis. With continued improvements in procedural techniques and device designs, TAVR is preferred for its minimally invasive nature, affording shorter recovery times and reduced hospital stays. In contrast, Mitral Valve Repair Devices are emerging as a vital segment due to innovative product developments and increasing clinical trials supporting their use. These devices offer effective solutions for mitral regurgitation, leveraging cutting-edge technology that resonates with the growing preference for less invasive surgical interventions while also being supported by expanding reimbursement frameworks.

### By Procedure Type: Minimally Invasive (Largest) vs. Surgical (Fastest-Growing)

In the GCC structural heart-devices market, the distribution of market share among the procedure types is characterized by a significant dominance of minimally invasive techniques, which are favored for their reduced recovery times and lower risk of complications. Surgical interventions follow, but their growth is being outpaced by percutaneous procedures, which are becoming increasingly popular due to advancements in technology that enhance their safety and efficacy.

The growth trends within this segment are being driven by several factors, including an increasing prevalence of structural heart diseases, a rise in the aging population, and continual innovations in device technology. As healthcare providers increasingly focus on patient-centric care, the demand for minimally invasive and percutaneous procedures is expected to surge, positioning them as critical components in the evolving landscape of the GCC structural heart-devices market.

Minimally Invasive (Dominant) vs. Surgical (Emerging)

Minimally invasive procedures are leading the way in the GCC structural heart-devices market due to their numerous advantages, including shorter hospital stays, minimal scarring, and quicker recovery for patients. These techniques are widely accepted among both healthcare professionals and patients, which contributes to their dominant market position. In contrast, surgical procedures, while traditionally seen as the standard approach for many heart conditions, are now regarded as emerging due to the growing interest in less invasive options. With evolving technology and training, surgical procedures are expected to adapt, improving their efficacy and safety, thus making them more competitive in the marketplace.

### By Indication: Aortic Stenosis (Largest) vs. Mitral Regurgitation (Fastest-Growing)

In the GCC structural heart-devices market, Aortic Stenosis dominates with the largest market share, exploiting the increasing prevalence of this condition in the region. Mitral Regurgitation has gained attention as the fastest-growing segment. The rising incidence of valvular heart diseases and advancements in treatment options are further influencing this market distribution.

Growth trends indicate a significant uptick in the adoption of innovative therapies and devices for heart valve conditions. The GCC region is witnessing increased healthcare expenditure, and this is facilitated by a greater focus on early diagnosis and treatment protocols. Factors such as lifestyle changes, aging populations, and heightened awareness among clinicians are driving the demand for structural heart devices, particularly in the Mitral Regurgitation segment.

Aortic Stenosis (Dominant) vs. Heart Failure (Emerging)

Aortic Stenosis is firmly entrenched as the dominant segment in the GCC structural heart-devices market, characterized by robust treatment pathways and a well-established body of clinical research. Patients suffering from Aortic Stenosis typically require timely interventions to prevent severe complications, creating a steady demand for valve replacement devices. Conversely, Heart Failure, while currently considered an emerging segment, shows significant potential for growth due to rising patient awareness and a shift towards comprehensive heart failure management solutions. Innovations in device technology, enhanced patient monitoring, and integrated care approaches are set to redefine treatment modalities in Heart Failure, paving the way for increased market share in the coming years.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the GCC structural heart-devices market, hospitals represent the largest segment, commanding a significant portion of the market share due to their comprehensive facilities and specialized care. Ambulatory surgical centers, while smaller in comparison, are rapidly gaining traction, appealing to a demographic that values efficiency and lower costs. The cardiology clinics segment, although vital, is positioned as a niche provider within this landscape, focusing on specialized heart care services.

Growth trends in this segment reveal a strong inclination towards minimally invasive procedures, driving the demand for advanced structural heart devices. Factors contributing to this growth include an increasing prevalence of cardiovascular diseases, improved patient awareness, and the expansion of healthcare services in the region. Furthermore, technological advancements and favorable reimbursement policies are enhancing service offerings in hospitals and ambulatory surgical centers, ultimately fostering market expansion.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals dominate the GCC structural heart-devices market as they typically feature comprehensive infrastructure, skilled medical professionals, and a wide array of treatment options. This enables them to cater to a diverse patient population with varying needs. In contrast, ambulatory surgical centers are emerging rapidly due to their cost-effectiveness and focus on outpatient procedures. They provide patients with less invasive surgical options and quicker recovery times, making them increasingly popular. As healthcare shifts towards value-based care, both segments are adapting; hospitals are enhancing their technological capabilities, while ambulatory centers are expanding their service offerings to compete effectively. Ultimately, the collaboration between these segments is essential for advancing patient care in the region.

## Competitive Benchmarking

The structural heart-devices market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Key players such as Edwards Lifesciences (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Edwards Lifesciences (US) emphasizes its commitment to research and development, particularly in transcatheter heart valves, which positions it favorably against competitors. Medtronic (US) has adopted a strategy of regional expansion, particularly in emerging markets, while Abbott Laboratories (US) is leveraging its strong portfolio of minimally invasive devices to capture a larger market share. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological innovation and patient-centric solutions.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for dominance. However, the collective influence of major companies like Boston Scientific (US) and LivaNova (GB) is significant, as they continue to innovate and expand their product offerings. This competitive structure fosters an environment where collaboration and strategic alliances are essential for sustained growth.

In October  Boston Scientific (US) announced the launch of its latest transcatheter mitral valve replacement system, which is expected to revolutionize treatment options for patients with mitral valve disease. This strategic move underscores the company's commitment to innovation and positions it as a leader in the structural heart-devices market. The introduction of this advanced technology is likely to enhance patient outcomes and solidify Boston Scientific's competitive edge.

In September  LivaNova (GB) entered into a partnership with a leading research institution to develop next-generation heart valve technologies. This collaboration aims to leverage cutting-edge research to accelerate product development and improve clinical outcomes. Such strategic alliances are indicative of the company's focus on innovation and its intent to remain competitive in a rapidly evolving market.

In August  Medtronic (US) expanded its manufacturing capabilities in the GCC region, aiming to enhance its supply chain efficiency and reduce lead times for product delivery. This strategic expansion not only strengthens Medtronic's operational capabilities but also reflects its commitment to meeting the growing demand for structural heart devices in the region. The move is expected to bolster the company's market presence and improve its responsiveness to customer needs.

As of November  current trends in the structural heart-devices market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, advanced technology, and supply chain reliability. This shift suggests that companies that prioritize these aspects will be better positioned to thrive in the future.

## Recent News & Developments

_The GCC Structural Heart Devices Market has recently seen significant developments, particularly from key players such as Medtronic, Abbott Laboratories, and Boston Scientific. In October 2023, Medtronic announced a partnership with several healthcare institutions across the GCC for the introduction of innovative heart valve therapies, responding to the rising prevalence of cardiovascular diseases in the region. Additionally, Abbott Laboratories revealed advancements in their medical devices aimed at improving patient outcomes, showcasing their continued commitment to Research and Development in the region. _

In terms of mergers and acquisitions, there have been whispers regarding possible acquisition discussions involving Terumo and AtriCure as of September 2023. The market is poised for growth due to increased investments in healthcare infrastructure across the GCC, driven by government initiatives aimed at enhancing health services. The overall market valuation of structural heart devices is projected to rise, reflecting the increasing demand for advanced medical solutions.

Recently, the UAE Ministry of Health and Prevention also indicated an ongoing trend toward the localization of medical manufacturing, which is likely to impact supply chains and the availability of these devices in the region moving forward.

## Report Scope

| MARKET SIZE 2024 | 19.25(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 20.54(USD Million) |
| MARKET SIZE 2035 | 39.36(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.72% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US) |
| Segments Covered | Type, Procedure Type, Indication, End User |
| Key Market Opportunities | Advancements in minimally invasive procedures enhance growth potential in the structural heart-devices market. |
| Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in structural heart-devices within the GCC region. |
| Countries Covered | GCC |

## Frequently Asked Questions

**Q: What was the market valuation of the structural heart-devices market in 2024?**
A: The market valuation was $19.25 Million in 2024.

**Q: What is the projected market valuation for 2035?**
A: The projected market valuation for 2035 is $39.36 Million.

**Q: What is the expected CAGR for the structural heart-devices market during the forecast period 2025 - 2035?**
A: The expected CAGR is 6.72% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the structural heart-devices market?**
A: Key players include Edwards Lifesciences, Medtronic, Abbott Laboratories, Boston Scientific, and others.

**Q: What are the main segments of the structural heart-devices market?**
A: Main segments include Type, Procedure Type, Indication, and End User.

**Q: What was the valuation for Transcatheter Aortic Valve Replacement in 2024?**
A: The valuation for Transcatheter Aortic Valve Replacement was between $5.0 Million and $10.0 Million.

**Q: How much is the Mitral Valve Repair Devices segment projected to be worth by 2035?**
A: The Mitral Valve Repair Devices segment is projected to be worth between $4.5 Million and $9.0 Million.

**Q: What is the valuation range for Minimally Invasive procedures in 2024?**
A: The valuation range for Minimally Invasive procedures was between $5.0 Million and $10.0 Million.

**Q: Which end user segment had the highest valuation in 2024?**
A: The Hospitals segment had the highest valuation, ranging from $8.0 Million to $16.0 Million.

**Q: What indications are driving the growth of the structural heart-devices market?**
A: Indications driving growth include Aortic Stenosis, Mitral Regurgitation, and Heart Failure.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gcc-structural-heart-devices-market-56905*